Abstract
The advent of genomics approaches to studying human disease have yielded a large number of genes and gene families that are involved in the process of bone formation and bone remodeling. The identification and characterization of these genes has provided significant insights into the pathogenesis of numerous human bone diseases. This review details current understanding of the role of many of these genes in bone development and disease. We review the current status of bone disease prevention/treatment modalities and describe how recent advances in our understanding of the molecules responsible for different aspects of osteoblast, osteoclast and chondrocyte function may provide novel biochemical markers and treatment strategies for bone disease.
Keywords: Bone Disease, Aromatase Deficieny, linked dominant Conradi-Hunermann, Down Syndrome skeletal abnormalities, Ellis-van Creveld syndrome, Crouzon syndrome, Apert syndrome, Pfeiffer syndrome, multiple epiphyseal dysplasia (MED), achondroplasia
Current Genomics
Title: Bone Disease - Current Knowledge and Future Prospects
Volume: 2 Issue: 2
Author(s): Francesca Lazner, Ernst Wolvetang, Daniel Lazner and Paul Hertzog
Affiliation:
Keywords: Bone Disease, Aromatase Deficieny, linked dominant Conradi-Hunermann, Down Syndrome skeletal abnormalities, Ellis-van Creveld syndrome, Crouzon syndrome, Apert syndrome, Pfeiffer syndrome, multiple epiphyseal dysplasia (MED), achondroplasia
Abstract: The advent of genomics approaches to studying human disease have yielded a large number of genes and gene families that are involved in the process of bone formation and bone remodeling. The identification and characterization of these genes has provided significant insights into the pathogenesis of numerous human bone diseases. This review details current understanding of the role of many of these genes in bone development and disease. We review the current status of bone disease prevention/treatment modalities and describe how recent advances in our understanding of the molecules responsible for different aspects of osteoblast, osteoclast and chondrocyte function may provide novel biochemical markers and treatment strategies for bone disease.
Export Options
About this article
Cite this article as:
Lazner Francesca, Wolvetang Ernst, Lazner Daniel and Hertzog Paul, Bone Disease - Current Knowledge and Future Prospects, Current Genomics 2001; 2 (2) . https://dx.doi.org/10.2174/1389202013351048
DOI https://dx.doi.org/10.2174/1389202013351048 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Statins and Cardiovascular Diseases: From Cholesterol Lowering to Pleiotropy
Current Pharmaceutical Design Abeta Immunotherapy and Other Means to Remove Amyloid
Current Drug Targets - CNS & Neurological Disorders β-Lactam Cholesterol Absorption Inhibitors
Current Medicinal Chemistry Expression and Role of the Calcium-Sensing Receptor in the Blood Vessel Wall
Current Pharmaceutical Biotechnology Mechanisms and Inhibitors of Apoptosis in Cardiovascular Diseases
Current Pharmaceutical Design Targeting CD4 to Disrupt Signaling Through Membrane Rafts: Towards a Raft-Based Therapeutics
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Hypertension: Quo Vadis?
Current Vascular Pharmacology Recent Advances in Health Promoting Effect of Dietary Polyphenols
Current Nutrition & Food Science The Study of HFE Genotypes and Its Expression Effect on Iron Status of Iranian Haemochromatosis, Iron Deficiency Anemia Patients, Iron-Taker and Non Iron-Taker Controls
Recent Advances in DNA & Gene Sequences (Discontinued) Allosteric Regulators of the Proteasome: Potential Drugs and a Novel Approach for Drug Design
Current Medicinal Chemistry Non Enzymatic Glycated Proteins in the Blood and Cardiovascular Disease
Current Pharmaceutical Design Natriuretic Peptides in Coronary Disease With Non-ST Elevation: New Tools Ready for Clinical Application?
Recent Patents on Cardiovascular Drug Discovery An Introduction to the Nutrition and Metabolism of Choline
Central Nervous System Agents in Medicinal Chemistry Cardioprotective Effects of Sour Cherry Seed Extract (SCSE) on the Hypercholesterolemic Rabbit Heart
Current Pharmaceutical Design Renin Angiotensin System (RAS) and Immune System Profile in Specific Subgroups with COVID-19
Current Medicinal Chemistry The Many Roles of Statins in Ischemic Stroke
Current Neuropharmacology The Effect of Antihypertensive Agents on Insulin Sensitivity, Lipids and Haemostasis
Current Vascular Pharmacology The Role of Mass Spectrometry in the “Omics” Era
Current Organic Chemistry Practical Recommendations for Familial Combined Hyperlipidemia Diagnosis and Management: An Update
Vascular Disease Prevention (Discontinued) Transthyretin Cardiac Amyloidosis and Aortic Stenosis: Connection and Therapeutic Implications
Current Cardiology Reviews